LILY34:BVMF
Eli Lilly And Company BDR
R$272.15
0.00%
(0.00) 1D
Nov 13, 6:06:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LILY34...
Mkt. cap
1.36T
Avg. vol.
52.12K
Volume
0.00
52-wk high
R$281.50
52-wk low
R$141.59
Shares outstanding
940.75M
No. of employees
50K
Mkt. cap
1.36T
Avg. vol.
52.12K
Volume
0.00
52-wk high
R$281.50
52-wk low
R$141.59
Shares outstanding
940.75M
No. of employees
50K
News stories
From web sources and news partners
Investing.com South Africa
·
39 minutes ago
Eli Lilly to buy Calytrix Bio for up to $1.5 bln By Investing.com
Reuters
·
1 hour ago
Lilly to buy Calytrix Bio for up to $1.5 billion
marketscreener.com
·
1 hour ago
Barclays Adjusts Price Target on Eli Lilly and Company to $1,550 From $1,400
Digital Health News
·
4 hours ago
Eli Lilly’s $1 Bn Hyderabad Investment Gets Fresh Push from Telangana CM
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Company BDR
CEODavid A. Ricks
Employees50K
Founded1876
HeadquartersIndianapolis, Indiana, United States
SectorHealth Care
IndustryPharmaceutical industry
Websitelilly.com